← Back to headlines
ImmunityBio Reports Q4 GAAP EPS of -$0.06 and Revenue of $38.2M
ImmunityBio announced its GAAP earnings per share of -$0.06 and reported revenue of $38.2 million for the latest quarter.
23 Feb, 13:06 — 23 Feb, 13:06
ℹOnly 1 source covers this story
